
Stock·NASDAQ·Technology
Sunrun Inc. (RUN)
- Market cap
- $1.75B
- Dividend yield
- None
- Street target
- $13.50median of 20 analysts
- 52-week range
- $6.78 $21.95
RUN stock forecast today
Where RUN stands today, and what CleaRank Financial AI makes of it.
RUN at a glance
Sunrun Inc. (RUN): Hold, 54/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($8.29 and $12.64).
- Insiders Insiders sold $29.4M and bought $693K over the last 18 months.
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates Sunrun Inc. (RUN) Hold, with a model score of 54/100.
The trend holds it back most: the price is 42.50% below its 200-day average and 12.30% below its 50-day average, and the 50-day average is 34.43% below the 200-day. The 50-day average stands at $8.29 and the 200-day at $12.64. Over the past year the price fell 65.13%.
Only on CleaRank
Figures we compute ourselves from RUN's own price, earnings and insider-filing history. Tap one to see it in context.
RUN stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $7.27 is 12.3% below the 50-day simple moving average of $8.29.Price above its 200-day average ›
The price is 42.5% below the 200-day simple moving average of $12.64.50-day average above the 200-day ›
The 50-day average ($8.29) is 34.4% below the 200-day average ($12.64), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 3% of its 52-week range, between $6.78 and $21.95.
RUN share price
Pick a period: each tab shows how far RUN has moved over it, to the last close.
Today's trading
Where RUN sits inside today's range and its 52-week range.
RUN fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/2P/S below the sector median ›
The price-to-sales ratio of 0.50 is 93.4% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was -$958.5M on revenue of $3.5B, a net margin of -27.6%.
Key statistics
The headline figures for RUN.
As of October 26, 2026, RUN trades at $7.27, with a market value of $1.75B.
What the numbers say
CleaRank Financial AI's reading of RUN's valuation, growth and risks.
On sales, the P/S of 0.50 is 93.4% below the sector median P/S of 7.6.
Revenue grew 52.80% in the latest quarter year on year, which is 28.6 percentage points ahead of the 24.2% median for Technology. RUN turns sales into profit at a net margin of -27.6% and an operating margin of 4.00%, alongside a return on equity of -19.86%, below the sector median of 13.4%. It also reports debt-to-equity of 2.93.
RUN reported $0.42 a share in its latest quarterly report, dated August 5, 2026, against an estimate of $0.25. That was a beat of 68.00% over the estimate. Despite the beat, the share price dropped 10.58% in the first session after the report.
The earnings record shows 1 beat in 2 reports, yet the stock fell in the first session after that beat. The November 6, 2025 report stands out among the earlier ones: a miss of 50.00%, after which the stock fell 16.11%. The consensus EPS estimate stands at $1.40 for this fiscal year and $0.52 for next, a decline of 18.3% for the current year.
RUN's price typically moves 3.79% on a given day, based on the 30-day standard deviation of its daily returns, and its beta against the S&P 500 is 2.44. Continued trading under both moving averages keeps the downtrend a live risk. The price is also 66.88% below its 52-week high of $21.95. Insider sales over the last 18 months came to $29.4M, while insider purchases totalled $693K. Sales are often planned ahead or made to cover tax on vesting shares, so they carry less weight than buying does.
RUN against the Technology sector
How RUN compares with the median Technology stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, RUN trades at 0.5038x, far below the sector average of 7.60x.
Return vs XLK: Since May 14, 2025, RUN has lost 42.8% against a gain of 59.2% for XLK.
Performance against XLK
RUN and the Technology sector fund over the same days.
Revenue and earnings
How much RUN sells, and how much of it becomes profit.
Revenue growth: Revenue grew 45.1% in FY2025 to $3.0B, from $2.0B a year earlier.
Profit margin: The net margin was -34.1% in FY2025, up from -213.7% the year before.
Loss-making: RUN lost $1.0B in FY2025.
Earnings reality check
Did RUN beat what analysts expected, and how did the stock react?
Earnings record: RUN beat the analyst estimate in 1 of the last 2 quarters.
Market reaction: The stock fell in the first session after that beat, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 5, 2026after close | $0.25 | $0.42 | +68.00% | -10.58% | -6.20% |
| Nov 6, 2025after close | $0.12 | $0.06 | -50.00% | -16.11% | -7.59% |
As of October 26, 2026, RUN has beaten the analyst EPS estimate in 1 of its last 2 reported quarters and fell in the first trading session after it; its latest report, on August 5, 2026, came in 68.00% above the estimate and the stock moved -10.58% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
RUN AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 41.3, in neutral territory.RSI above 50 ›
An RSI of 41.3 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of RUN
The score, the reasoning behind it, and what could move the price next.
Sunrun Inc. (RUN) is priced at $7.27, below both of its main moving averages. The stock sits 12.30% below its 50-day average of $8.29 and 42.50% below its 200-day average of $12.64. Within its 52-week range it is at 3%, and the price is 7.23% above the 52-week low of $6.78. The two averages point the same way, with the 50-day 34.43% below the 200-day.
The price is down over each of these periods: 10.36% over the past month, 27.15% over the past three months and 65.13% over the past year. On momentum, the 14-day RSI reads 41.3, in the neutral zone, with the MACD line negative.
Earnings beat, but the stock fell ›
The August 5, 2026 report beat the EPS estimate by 68.00%, and the share price fell 10.58% in the first session after it.
Source: Earnings report, August 5, 2026Rating reaffirmed ›
Morgan Stanley kept its Equal-Weight rating on October 14, 2026.
Source: Analyst action, Morgan Stanley, October 14, 2026
- The two nearest levels to watch are the 20-day EMA at $7.66, which sits above the price, and the 52-week low at $6.78, which sits below it.
- A 14-day RSI of 41.3 sits in the neutral zone, and the MACD line is negative. Readings above 70 or below 30 point to stretched momentum.
- The share price fell 10.58% in the first session after the August 5, 2026 report. RUN has beaten estimates in 1 of its last 2 reports.
RUN remains in a downtrend while it sits below both its 50-day average of $8.29 and its 200-day average of $12.64. A close back above the 50-day average would be the first sign of a repair. Overhead, the 20-day EMA at $7.66 is the nearest hurdle.
The next level below the price is the 52-week low of $6.78.
Technical indicators
Momentum and trend for RUN, from its daily closes.
As of October 26, 2026, with RUN at $7.27, its 14-day RSI is 41.3 (neutral territory), its 50-day simple moving average is $8.29 and its 200-day is $12.64.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What RUN moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, RUN's 1-year correlation of daily returns is +0.25 with S&P 500 (SPY), +0.25 with Nasdaq 100 (QQQ), +0.25 with Bitcoin (BTC) and +0.12 with gold (XAU).
RUN price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
11 of 20 analysts rate it a buy or strong buy, 9 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $13.50 is 85.7% above the price.More buy ratings than three months ago ›
11 of 20 rate it a buy now, against 12 of 22 three months ago.
RUN Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 14, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Oct 14, 2026 | Susquehanna | Maintains | Positive |
| Oct 9, 2026 | Citigroup | Maintains | Buy |
| Oct 9, 2026 | Barclays | Maintains | Equal-Weight |
| Oct 8, 2026 | Goldman Sachs | Maintains | Buy |
| Sep 21, 2026 | Goldman Sachs | Maintains | Buy |
As of October 26, 2026, 20 Wall Street analysts cover RUN: 11 rate it a buy or strong buy, 9 a hold and 0 a sell or strong sell. Their 12-month price targets range from $7.00 to $30.00. The median RUN price target is $13.50, 85.7% above the price of $7.27.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
RUN trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
RUN trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
RUN moves about 3.8% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much RUN tends to move, against the market and on its own.
RUN price history and drawdowns
RUN's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 3.79% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 93.8%, from January 2021 to April 2025; the price is still 92.0% below that peak.Most 1-year holds ended higher ›
52% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $13,538, against $42,015 in the S&P 500 (SPY).
RUN Drawdowns & Recovery
As of October 26, 2026, RUN's worst peak-to-trough fall over the last 10 years with dividends reinvested was -93.8% (January 2021 to April 2025); it is still 92.0% below that peak, and 52% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into RUN in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: RUN trailed the S&P 500 over this period: $13,538 against $42,015.
A $10,000 investment in RUN in October 2016 would be worth about $13,538 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to RUN, and which have not.
Strongest month, July: an average of +14.34%, up in 7 of 10 years.
Weakest month, March: an average of -6.90%, up in 3 of 10 years.
This month, October: has averaged -5.07%, up in 2 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, RUN's strongest calendar month has been July (average +14.34%, up in 7 of 10 years) and its weakest March (average -6.90%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
RUN stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in RUN, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in RUN today could grow to about $12,050 by 2030 in the base case, with a 90th-percentile outcome near $43,409 and a 10th-percentile outcome around $3,345. Projections are statistical simulations, not guarantees.
RUN Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $8.76 for RUN by 2030 in the base case, from $7.27 today (1.2x over 4 years). The 10th-percentile path ends near $2.43. These are outcomes of a Monte Carlo simulation run on RUN's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $4.01 | $7.62 | $14.46 | |
| 2028 | $3.22 | $7.98 | $19.75 | |
| 2029 | $2.76 | $8.36 | $25.37 | |
| 2030 | $2.43 | $8.76 | $31.56 |
Method: a lognormal simulation of RUN's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
RUN insider trading
What the people running the company have bought and sold.
RUN insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $693K on the open market and sold $29.4M.
As of October 26, 2026, RUN insiders reported 83 open-market sales worth $29.4M and 2 open-market purchases worth $693K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Mary G Powell
Chief Executive Officer
|
Sell | 24.3K | $188.9K |
| Oct 6, 2026 | Danny Abajian
Chief Financial Officer
|
Sell | 16.7K | $129.9K |
| Oct 6, 2026 | Paul S Dickson
President
|
Sell | 15.8K | $123.0K |
| Oct 6, 2026 | Jeanna C Steele
Officer
|
Sell | 10.0K | $78.0K |
| Oct 6, 2026 | Maria Barak
Officer
|
Sell | 1.8K | $13.8K |
| Oct 6, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 16.8K | - |
| Aug 3, 2026 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $498.1K |
| Jul 9, 2026 | Maria Barak
Officer
|
Sell | 3.3K | $39.9K |
| Jul 6, 2026 | Mary G Powell
Chief Executive Officer
|
Sell | 24.0K | $316.3K |
| Jul 6, 2026 | Danny Abajian
Chief Financial Officer
|
Sell | 16.5K | $217.5K |
| Jul 6, 2026 | Paul S Dickson
President
|
Sell | 15.6K | $205.9K |
| Jul 6, 2026 | Jeanna C Steele
Officer
|
Sell | 9.9K | $130.5K |
| Jul 6, 2026 | Maria Barak
Officer
|
Sell | 1.7K | $23.0K |
| Jul 6, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 17.1K | - |
| Jul 1, 2026 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $680.3K |
| Jul 1, 2026 | Edward Harris Fenster
Director
|
Grant | 8.3K | - |
| Jul 1, 2026 | Lynn Michelle Jurich
Director
|
Grant | 8.3K | - |
| Jun 11, 2026 | Sonita Lontoh
Director
|
Sell | 7.5K | $90.0K |
| Jun 8, 2026 | Danny Abajian
Chief Financial Officer
|
Sell | 2.0K | $27.2K |
| Jun 8, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 2.0K | - |
| Jun 1, 2026 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $796.2K |
| May 1, 2026 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $644.5K |
| Apr 10, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 130.6K | - |
| Apr 10, 2026 | Maria Barak
Officer
|
Grant | 20.1K | - |
| Apr 10, 2026 | Paul S Dickson
President
|
Grant | 148.0K | - |
| Apr 10, 2026 | Mary G Powell
Chief Executive Officer
|
Grant | 201.2K | - |
| Apr 10, 2026 | Jeanna C Steele
Officer
|
Grant | 87.1K | - |
| Apr 9, 2026 | Maria Barak
Officer
|
Sell | 8.0K | $109.9K |
| Apr 6, 2026 | Mary G Powell
Chief Executive Officer
|
Sell | 193.0K | $2.6M |
| Apr 6, 2026 | Danny Abajian
Chief Financial Officer
|
Sell | 133.0K | $1.8M |
| Apr 6, 2026 | Paul S Dickson
President
|
Sell | 127.7K | $1.7M |
| Apr 6, 2026 | Jeanna C Steele
Officer
|
Sell | 76.5K | $1.0M |
| Apr 6, 2026 | Maria Barak
Officer
|
Sell | 4.6K | $61.5K |
| Apr 6, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 123.5K | - |
| Apr 1, 2026 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $703.6K |
| Mar 6, 2026 | Mary G Powell
Chief Executive Officer
|
Sell | 2.2K | $26.6K |
| Mar 6, 2026 | Danny Abajian
Chief Financial Officer
|
Sell | 1.4K | $16.9K |
| Mar 6, 2026 | Paul S Dickson
President
|
Sell | 1.1K | $13.0K |
| Mar 6, 2026 | Jeanna C Steele
Officer
|
Sell | 901 | $10.8K |
| Mar 6, 2026 | Lynn Michelle Jurich
Director
|
Sell | 450 | $5.4K |
| Mar 6, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 2.6K | - |
| Mar 3, 2026 | Alan D Ferber
Director
|
Buy | 12.5K | $149.0K |
| Mar 2, 2026 | Lynn Michelle Jurich
Director
|
Sell | 55.5K | $703.8K |
| Mar 2, 2026 | Mary G Powell
Chief Executive Officer
|
Sell | 5.4K | $66.1K |
| Mar 2, 2026 | Danny Abajian
Chief Financial Officer
|
Sell | 4.2K | $51.7K |
| Mar 2, 2026 | Jeanna C Steele
Officer
|
Sell | 1.1K | $13.6K |
| Mar 2, 2026 | Paul S Dickson
President
|
Sell | 1.0K | $12.6K |
| Mar 2, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 6.7K | - |
| Feb 27, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 185.3K | - |
| Feb 27, 2026 | Paul S Dickson
President
|
Grant | 197.8K | - |
| Feb 27, 2026 | Edward Harris Fenster
Director
|
Grant | 5.6K | - |
| Feb 27, 2026 | Lynn Michelle Jurich
Director
|
Grant | 12.7K | - |
| Feb 27, 2026 | Mary G Powell
Chief Executive Officer
|
Grant | 269.9K | - |
| Feb 27, 2026 | Mary G Powell
Chief Executive Officer
|
Grant | 270.6K | - |
| Feb 27, 2026 | Jeanna C Steele
Officer
|
Grant | 107.5K | - |
| Feb 11, 2026 | Edward Harris Fenster
Director
|
Sell | 163.8K | $3.3M |
| Feb 11, 2026 | Edward Harris Fenster
Director
|
Grant | 25.0K | - |
| Feb 11, 2026 | Edward Harris Fenster
Director
|
Option | 250.6K | $1.3M |
| Feb 2, 2026 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $929.7K |
| Jan 9, 2026 | Maria Barak
Officer
|
Sell | 1.6K | $30.2K |
| Jan 6, 2026 | Mary G Powell
Chief Executive Officer
|
Sell | 8.8K | $155.8K |
| Jan 6, 2026 | Danny Abajian
Chief Financial Officer
|
Sell | 7.2K | $128.0K |
| Jan 6, 2026 | Paul S Dickson
President
|
Sell | 6.1K | $108.9K |
| Jan 6, 2026 | Jeanna C Steele
Officer
|
Sell | 4.4K | $78.8K |
| Jan 6, 2026 | Maria Barak
Officer
|
Sell | 1.2K | $21.4K |
| Jan 6, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 10.9K | - |
| Jan 2, 2026 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $963.9K |
| Jan 2, 2026 | Katherine August-Dewilde
Director
|
Grant | 9.7K | - |
| Jan 2, 2026 | Craig Cornelius
Director
|
Grant | 9.7K | - |
| Jan 2, 2026 | Leslie A Dach
Director
|
Grant | 9.7K | - |
| Jan 2, 2026 | Alan D Ferber
Director
|
Grant | 9.7K | - |
| Jan 2, 2026 | Sonita Lontoh
Director
|
Grant | 9.7K | - |
| Jan 2, 2026 | John Trinta
Director
|
Grant | 9.7K | - |
| Dec 22, 2025 | Edward Harris Fenster
Director
|
Sell | 32.8K | $655.7K |
| Dec 22, 2025 | Edward Harris Fenster
Director
|
Option | 50.0K | $254.0K |
| Dec 8, 2025 | Mary G Powell
Chief Executive Officer
|
Sell | 2.9K | $51.5K |
| Dec 8, 2025 | Paul S Dickson
President
|
Sell | 2.4K | $42.2K |
| Dec 8, 2025 | Danny Abajian
Chief Financial Officer
|
Sell | 2.0K | $35.7K |
| Dec 8, 2025 | Jeanna C Steele
Officer
|
Sell | 1.9K | $33.3K |
| Dec 8, 2025 | Lynn Michelle Jurich
Director
|
Sell | 451 | $8.0K |
| Dec 8, 2025 | Danny Abajian
Chief Financial Officer
|
Grant | 2.0K | - |
| Dec 5, 2025 | Edward Harris Fenster
Director
|
Sell | 133.3K | $2.4M |
| Dec 5, 2025 | Edward Harris Fenster
Director
|
Option | 200.0K | $1.0M |
| Dec 1, 2025 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $978.7K |
| Nov 13, 2025 | Maria Barak
Officer
|
Sell | 6.3K | $121.6K |
| Nov 6, 2025 | Craig Cornelius
Director
|
Grant | 1.4K | - |
| Nov 3, 2025 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $1.0M |
| Oct 15, 2025 | Jeanna C Steele
Officer
|
Sell | 4.5K | $97.1K |
| Oct 9, 2025 | Jeanna C Steele
Officer
|
Sell | 21.0K | $426.0K |
| Oct 8, 2025 | Jeanna C Steele
Officer
|
Sell | 6.0K | $116.0K |
| Oct 7, 2025 | Paul S Dickson
President
|
Sell | 20.6K | $407.4K |
| Oct 7, 2025 | Paul S Dickson
President
|
Option | 12.5K | $112.5K |
| Oct 6, 2025 | Mary G Powell
Chief Executive Officer
|
Sell | 11.7K | $226.3K |
| Oct 6, 2025 | Danny Abajian
Chief Financial Officer
|
Sell | 9.1K | $175.2K |
| Oct 6, 2025 | Maria Barak
Officer
|
Sell | 1.0K | $19.4K |
| Oct 6, 2025 | Danny Abajian
Chief Financial Officer
|
Grant | 9.0K | - |
| Oct 1, 2025 | Lynn Michelle Jurich
Director
|
Sell | 100.0K | $1.8M |
| Oct 1, 2025 | Paul S Dickson
President
|
Sell | 25.6K | $512.3K |
| Oct 1, 2025 | Jeanna C Steele
Officer
|
Sell | 20.4K | $395.2K |
| Oct 1, 2025 | Paul S Dickson
President
|
Option | 4.9K | $30.7K |
| Sep 8, 2025 | Mary G Powell
Chief Executive Officer
|
Sell | 3.1K | $53.2K |
| Sep 8, 2025 | Paul S Dickson
President
|
Sell | 2.6K | $43.6K |
| Sep 8, 2025 | Danny Abajian
Chief Financial Officer
|
Sell | 2.2K | $36.9K |
| Sep 8, 2025 | Jeanna C Steele
Officer
|
Sell | 1.4K | $24.3K |
| Sep 8, 2025 | Lynn Michelle Jurich
Director
|
Sell | 490 | $8.3K |
| Sep 8, 2025 | Danny Abajian
Chief Financial Officer
|
Grant | 1.8K | - |
| Sep 2, 2025 | Mary G Powell
Chief Executive Officer
|
Sell | 1.8K | $28.5K |
| Aug 26, 2025 | Jeanna C Steele
Officer
|
Sell | 7.1K | $118.5K |
| Aug 18, 2025 | Jeanna C Steele
Officer
|
Sell | 17.4K | $283.0K |
| Aug 13, 2025 | Alan D Ferber
Director
|
Sell | 10.9K | $122.8K |
| Jul 7, 2025 | Mary G Powell
Chief Executive Officer
|
Sell | 11.5K | $124.3K |
| Jul 7, 2025 | Danny Abajian
Chief Financial Officer
|
Sell | 8.9K | $96.3K |
| Jul 7, 2025 | Paul S Dickson
President
|
Sell | 8.0K | $86.6K |
| Jul 7, 2025 | Jeanna C Steele
Officer
|
Sell | 3.7K | $39.6K |
| Jul 7, 2025 | Maria Barak
Officer
|
Sell | 988 | $10.7K |
| Jul 7, 2025 | Danny Abajian
Chief Financial Officer
|
Grant | 9.1K | - |
| Jun 6, 2025 | Mary G Powell
Chief Executive Officer
|
Sell | 3.0K | $24.5K |
| Jun 6, 2025 | Paul S Dickson
President
|
Sell | 2.4K | $20.1K |
| Jun 6, 2025 | Danny Abajian
Chief Financial Officer
|
Sell | 1.6K | $13.2K |
| Jun 6, 2025 | Jeanna C Steele
Officer
|
Sell | 1.4K | $11.2K |
Source: TwelveData, from SEC Form 4 filings
RUN stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.
